COMMUNIQUÉS West-GlobeNewswire

Data on cenerimod – Idorsia's S1P1 receptor modulator – will be presented at the ACR / ARP Annual Meeting 2019

02/10/2019 - 17:35

Allschwil, Switzerland – October 2, 2019 Idorsia Ltd (SIX: IDIA) today announced that data from a Phase 2 study with cenerimod, a selective sphingosine-1-phosphate 1 (S1P 1 ) receptor modulator, will be shared during [...]

EssilorLuxottica : Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2019

02/10/2019 - 18:00

Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2019 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) [...]

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2019

02/10/2019 - 18:00

Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2019 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]

Allied Corp., a Medical Cannabis Company, Enters Into a Strategic Partnership Giving Access to The European Market

02/10/2019 - 18:23

KELOWNA, British Columbia, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied") (OTC: ALID), an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions, is [...]

‘Medicare for All’ Means Medicare for Nobody, States the Association of American Physicians and Surgeons (AAPS)

02/10/2019 - 18:51

TUCSON, Ariz., Oct. 02, 2019 (GLOBE NEWSWIRE) -- The Medicare in the Sanders Medicare-for-All bill is not the same program that retirees were taxed for their entire working lives, states the Association of American [...]

SciCann Therapeutics receives notice of allowance for its enhanced CBD therapy US patent for NASH

02/10/2019 - 19:06

TORONTO and TEL AVIV, Israel, Oct. 02, 2019 (GLOBE NEWSWIRE) -- SciCann Therapeutics is pleased to announce that it has received a notice of allowance from the United States Patent and Trademarks Office (USPTO) for its [...]

Vital, a Canon Group company, Recognized in Gartner’s Hype Cycle for Real-Time Health System Technologies, 2019 Report

02/10/2019 - 21:27

MINNETONKA, Minn., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Vital, a leading provider in Enterprise Imaging solutions, was named in the Gartner Hype Cycle for Real-Time Health System Technologies, 2019 report 1 . This report [...]

NEOVACS ANNOUNCES ITS 2019 HALF-YEAR RESULTS

02/10/2019 - 21:31

PRESS RELEASE PRESS RELEASE · PRESS RELEASE · PRESS RELEASE PRESS RELEASE NEOVACS ANNOUNCES ITS 2019 HALF-YEAR RESULTS Paris and Boston, 2 nd October, 2019— 9:30 p.m. CEST—NEOVACS (Euronext Paris: ALNEV, eligible for [...]

NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019

02/10/2019 - 21:31

COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019 Paris et Boston, le 2 octobre 2019 – 09 : 30 CEST - NÉOVACS (Euronext Paris : ALNEV, éligible PEA-PME), [...]

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

02/10/2019 - 22:00

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]

Monthly information regarding the total number of voting rights and total number of shares of the Company

02/10/2019 - 22:00

Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]

Lexicon Pharmaceuticals Announces Poster Presentations at the NANETS Annual Multidisciplinary NET Medical Symposium

02/10/2019 - 22:01

THE WOODLANDS, Texas, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that data from five posters highlighting XERMELO ® (telotristat ethyl) will be presented at the [...]

Aduro Biotech Announces Two Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer 34th Annual Meeting (SITC 2019)

02/10/2019 - 22:05

BERKELEY, Calif., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and [...]

EyePoint Pharmaceuticals Announces Permanent and Specific J-Code for YUTIQ® Now in Effect

02/10/2019 - 22:05

WATERTOWN, Mass., Oct. 02, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, [...]

Novadip Biosciences Presents Clinical Case Study on Next Generation Tissue Regeneration Therapy for Critical Size Bone Reconstruction at EORS Conference

02/10/2019 - 07:00

Novadip Biosciences Presents Clinical Case Study on Next Generation Tissue Regeneration Therapy for Critical Size Bone Reconstruction at EORS Conference Study highlights potential benefit in rare pediatric orthopedic [...]

Novartis positive 52-week PREVENT data confirm Cosentyx® efficacy in addressing entire axSpA spectrum

02/10/2019 - 07:15

Phase III PREVENT study met 52-week primary endpoint of ASAS40, showing a sustained response in patients with non-radiographic axial spondyloarthritis (nr-axSpA)[1] Novartis plans FDA submission for nr-axSpA, having [...]

Bone Therapeutics présentera des données précliniques sur les propriétés ostéogéniques d’ALLOB dans la régénération osseuse à l’occasion de la 27e réunion annuelle de l’EORS (European Orthopaedic Research Society)

02/10/2019 - 07:21

Communiqué de presse Gosselies, Belgique, le 2 octobre 2019, 07h00 CEST – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE, éligible PEA-PME), société de biotechnologie spécialisée dans le développement de [...]

Bone Therapeutics to present preclinical data on the osteogenic properties of ALLOB in bone repair at 27th Annual Meeting of the European Orthopaedic Research Society

02/10/2019 - 07:21

Press release Gosselies, Belgium, 2 October 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological therapies to [...]

Nicox : Les premiers résultats de l’étude de phase 2 Dolomites dans le glaucome montrent que le NCX 470 atteint le critère d’évaluation primaire et démontre une supériorité statistique vs. latanoprost

02/10/2019 - 07:30

Communiqué de presse Nicox : Les premiers résultats de l’étude de phase 2 Dolomites dans le glaucome montrent que le NCX 470 atteint le critère d’évaluation primaire et démontre une supériorité statistique vs. [...]